Protocol Section
The Protocol Section is one of the main sections in ClinicalTrials.gov data structure. It contains protocol-related information for clinical trials, including identification, status, design, eligibility, and other key details about how the trial is structured and conducted.
Protocol Section path is as follows:
Study -> Protocol Section -> Protocol Modules (Identification, Status, Design, Eligibility, etc.)
Protocol Section
Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2025-12-24 @ 4:31 PM
NCT ID:
NCT07301866
Description:
Description:
The sponsor plans to share IPD collected during the trial, including de-identified clinical data and biological sample results, with qualified researchers for secondary analyses. This includes data related to:
Primary and secondary endpoints (e.g., neutrophil engraftment, GVHD incidence, survival outcomes) Safety data (e.g., adverse events, serious adverse events) Demographic and baseline characteristics
What IPD Will Be Shared:
* De-identified individual-level clinical data
* Immune profiling and chimerism data
* Adverse event and safety data
* Outcome measures (e.g., engraftment times, relapse, survival)
Study:
NCT07301866
Study Brief:
A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.